These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36743218)

  • 1. Did Corporate Social Responsibility Vaccinate Corporations Against COVID-19?
    Poursoleyman E; Mansourfar G; Hassan MK; Homayoun S
    J Bus Ethics; 2023 Feb; ():1-27. PubMed ID: 36743218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corporate Social Responsibility Disclosure: Responding to Investors' Criticism on Social Media.
    Zhang Y; Yang F
    Int J Environ Res Public Health; 2021 Jul; 18(14):. PubMed ID: 34299847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can corporate social responsibility protect firm value during the COVID-19 pandemic?
    Qiu SC; Jiang J; Liu X; Chen MH; Yuan X
    Int J Hosp Manag; 2021 Feb; 93():102759. PubMed ID: 36919172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Socially stigmatized company's CSR efforts during the COVID-19 pandemic: The effects of CSR fit and perceived motives.
    Lee YJ; Cho M
    Public Relat Rev; 2022 Jun; 48(2):102180. PubMed ID: 35368969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moderating role of financial ratios in corporate social responsibility disclosure and firm value.
    Naseem MA; Lin J; Rehman RU; Ahmad MI; Ali R
    PLoS One; 2019; 14(4):e0215430. PubMed ID: 30998740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interfaces of occupational health management and corporate social responsibility: a multi-centre qualitative study from Germany.
    Kuhn E; Müller S; Teusch C; Tanner G; Schümann M; Baur C; Bamberg E; Heidbrink L; McLennan S; Buyx A
    BMC Public Health; 2021 Jun; 21(1):1042. PubMed ID: 34078332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real effects of social trust on firm performance during COVID-19.
    Ramesh VK; Athira A
    MDE Manage Decis Econ; 2022 Aug; ():. PubMed ID: 36247213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occupational safety and health aspects of corporate social responsibility (CSR) in Japanese companies listed on the Tokyo Stock Exchange (TSE) first section.
    Kawashita F; Taniyama Y; Hwi SY; Fujisaki T; Kameda T; Mori K
    J Occup Health; 2005 Nov; 47(6):533-9. PubMed ID: 16369117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corporate social responsibility and firm performance: Case of Kazakhstan.
    Katenova M; Qudrat-Ullah H
    Heliyon; 2024 May; 10(10):e31580. PubMed ID: 38826736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Impact of COVID-19 on the Stock Price of Socially Responsible Enterprises: An Empirical Study in Taiwan Stock Market.
    Lee KJ; Lu SL
    Int J Environ Res Public Health; 2021 Feb; 18(4):. PubMed ID: 33546396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of hotel CSR for strategic philanthropy on booking behavior and hotel performance during the COVID-19 pandemic.
    Shin H; Sharma A; Nicolau JL; Kang J
    Tour Manag; 2021 Aug; 85():104322. PubMed ID: 34815613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does CSR performance improve corporate immunity to the COVID-19 pandemic? Evidence from China's stock market.
    Tian J; Wang X; Wei Y
    Front Public Health; 2022; 10():956521. PubMed ID: 36052006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beyond COVID-19 Pandemic: An Integrative Review of Global Health Crisis Influencing the Evolution and Practice of Corporate Social Responsibility.
    Asante Antwi H; Zhou L; Xu X; Mustafa T
    Healthcare (Basel); 2021 Apr; 9(4):. PubMed ID: 33921512
    [No Abstract]   [Full Text] [Related]  

  • 14. Nexus between corporate social responsibility and firm's perceived performance: evidence from SME sector of developing economies.
    Yumei H; Iqbal W; Nurunnabi M; Abbas M; Jingde W; Chaudhry IS
    Environ Sci Pollut Res Int; 2021 Jan; 28(2):2132-2145. PubMed ID: 32875447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding the dynamics of capital structure, corporate governance, and corporate social responsibility in high- and low-leveraged US and Chinese firms.
    Mahmood AN; Arslan HM; Younas ZI; Komal B; Ali K; Mubeen M
    Environ Sci Pollut Res Int; 2023 Apr; 30(16):46204-46221. PubMed ID: 36710308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of socially responsible firms during the COVID-19 crisis and trading behavior by investor type: Evidence from the Korean stock market.
    Lee S; Lee D; Hong C; Park MH
    Financ Res Lett; 2022 Mar; 45():102660. PubMed ID: 35002551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The philanthropic response of substantive and symbolic corporate social responsibility strategies to COVID-19 crisis: Evidence from China.
    Zhong M; Zhao W; Shahab Y
    Corp Soc Responsib Environ Manag; 2022 Mar; 29(2):339-355. PubMed ID: 35465450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do financial performance and firm's value affect the quality of corporate social responsibility disclosure: Moderating role of chief executive officer's power in China.
    Na C; Tian G; Rauf F; Naveed K
    Front Psychol; 2022; 13():925323. PubMed ID: 36059787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stakeholders' Responses to CSR Tradeoffs: When Other-Orientation and Trust Trump Material Self-Interest.
    Bridoux F; Stofberg N; Den Hartog D
    Front Psychol; 2015; 6():1992. PubMed ID: 26834657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors Affecting the Implementation of Corporate Social Responsibility in the Health Technology Industry in Greece.
    Liopa M; Geitona M; Latsou D
    Cureus; 2023 Jun; 15(6):e39946. PubMed ID: 37409209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.